investig
whether
surfacelink
liposom
peptid
applic
vaccin
base
cytotox
lymphocyt
ctl
sever
acut
respiratori
syndrom
sar
coronaviru
sarscov
first
identifi
four
hlaa
ctl
epitop
deriv
sarscov
use
hlaa
transgen
mice
recombin
adenoviru
express
predict
epitop
peptid
coupl
surfac
liposom
inocul
mice
two
liposom
peptid
effect
peptidespecif
ctl
induct
one
effici
clearanc
vaccinia
viru
express
epitop
sarscov
suggest
surfacelink
liposom
peptid
might
offer
effect
ctlbase
vaccin
sar
sever
acut
respiratori
syndrom
sar
novel
infecti
diseas
emerg
southern
china
late
spread
sever
countri
earli
case
sar
identifi
worldwid
nearli
patient
die
epidem
end
etiolog
agent
sar
turn
novel
coronaviru
term
sarsassoci
coronaviru
sarscov
plusstrand
rna
viru
approxim
long
genom
encod
replicas
gene
product
structur
protein
contain
spike
envelop
e
membran
nucleocapsid
n
viral
genom
sequenc
viral
receptor
identifi
howev
pathogenesi
sar
remain
poorli
understood
appar
latenc
sarscov
anim
reservoir
continu
provid
us
seriou
threat
reemerg
therefor
urgent
develop
new
prophylact
therapeut
strategi
sar
among
four
structur
protein
sarscov
protein
interact
cellular
receptor
mediat
membran
fusion
allow
viru
enter
host
cell
accordingli
protein
major
target
neutral
antibodi
high
titer
neutral
antibodi
sarscov
detect
sera
recov
patient
humor
immun
induc
dna
vaccin
contribut
protect
sarscov
challeng
mice
data
impli
neutral
antibodi
play
critic
role
clearanc
sarscov
hand
rapid
loss
cell
observ
patient
suffer
sever
sar
cell
count
gradual
return
normal
rang
patient
recov
furthermor
certain
hla
class
allel
report
correl
sar
suscept
data
strongli
suggest
mani
viral
infect
virusspecif
cytotox
lymphocyt
ctl
import
viral
elimin
sar
well
synthet
peptid
vaccin
potenti
candid
ctlbase
vaccin
pathogen
virus
account
sever
advantag
convent
vaccin
first
synthet
peptid
rare
caus
undesir
respons
includ
gener
toxic
immunosuppress
autoimmun
second
possibl
select
short
peptid
absenc
amino
acid
mutat
third
synthet
peptid
easili
prepar
pure
immunogen
larg
quantiti
howev
major
disadvantag
weak
immunogen
therefor
critic
search
adjuv
vehi
cle
nonimmunogen
enhanc
immunogen
peptid
liposom
extens
investig
deliveri
system
antigen
case
prepar
antigen
entrap
within
aqueou
lumen
liposom
contrast
previous
shown
ovalbulim
ova
chemic
conjug
surfac
liposom
induc
ovaspecif
igg
product
ovaspecif
ige
product
mice
suggest
surfacelink
liposom
antigen
could
offer
safe
antigen
deliveri
system
without
allerg
side
effect
furthermor
demonstr
ovaderiv
peptid
ova
conjug
surfac
liposom
made
unsatur
satur
fatti
acid
induc
ova
specif
ctl
mice
effect
liposom
contain
ova
insid
addit
shown
surfacelink
liposom
peptid
abl
provid
tumor
erad
protect
viral
challeng
mice
taken
togeth
data
suggest
liposom
would
becom
excel
adjuv
vehicl
synthet
peptid
vaccin
peptid
chemic
coupl
surfac
liposom
current
studi
explor
possibl
surfacelink
liposom
peptid
might
serv
effect
ctlbase
vaccin
sar
firstli
attempt
identifi
hlaa
ctl
epitop
deriv
n
protein
sarscov
sarscovn
use
comput
algorithm
recombin
adenoviru
hlaa
transgen
mice
n
protein
chosen
analys
conserv
protein
peptid
identifi
chemic
conjug
surfac
liposom
evalu
abil
induc
sarscovnspecif
ctl
clear
viru
use
recombin
vaccinia
viru
express
sarscovderiv
epitop
defin
potenti
hlaa
peptid
deriv
sarscovn
urbani
strain
genbank
access
number
use
two
computerbas
program
syfpeithi
http
wwwsyfpeithid
bima
http
wwwbimascitnihgovmolbiohla
bind
shown
tabl
eight
peptid
high
score
select
synthes
operon
biotechnolog
tokyo
japan
ia
b
restrict
helper
cell
peptid
hepat
b
viru
hbv
core
amino
acid
sequenc
tppayrppnapil
also
synthes
use
immun
synthes
peptid
desalt
analyz
high
perform
liquid
chromatographi
hplc
mice
express
transgen
hlaa
monochain
design
hhd
human
microglobulin
coval
link
chimer
heavi
chain
compos
hlaa
domain
b
transmembran
cytoplasm
domain
eightto
mice
use
experi
mice
hous
appropri
anim
care
facil
saitama
medic
univers
saitama
japan
handl
accord
intern
guidelin
experi
anim
mous
lymphoma
cell
line
transfect
hhd
gene
rmahhd
b
previous
describ
tapdefici
human
lymphoblastoid
cell
line
express
natur
hlaa
human
kidney
cell
line
cell
obtain
american
type
cultur
collect
rockvil
md
african
green
monkeyderiv
kidney
cell
line
human
osteosarcoma
thymidin
kinasedefect
cell
line
kindli
provid
dr
shioda
osaka
univers
japan
cell
line
maintain
medium
sigmaaldrich
st
loui
mo
supplement
fetal
calf
serum
fc
jrh
bioscienc
lenexa
ks
cell
line
cultur
dulbecco
modifi
eagl
medium
dmem
sigmaaldrich
fc
rmahhd
cell
line
maintain
contain
sigmaaldrich
final
concentr
gml
peptid
bind
assay
perform
describ
briefli
cell
incub
synthet
peptid
variou
concentr
overnight
c
cell
stain
antihlaa
monoclon
antibodi
mab
follow
fluorescein
isothiocyan
fitc
label
goat
antimous
igg
sigmaaldrich
mean
fluoresc
intens
mfi
measur
flow
cytometri
facscan
bd
bioscienc
san
jose
ca
concentr
peptid
yield
halfmaxim
mfi
cell
puls
control
peptid
deriv
hepat
c
viru
hcv
calcul
halfmaxim
bind
level
bl
experi
perform
three
time
data
given
mean
valu
sd
multiepitop
minigen
encod
eight
predict
epitop
natur
flank
amino
acid
residu
n
c
termini
fig
construct
use
overlap
long
oligonucleotid
pcrbase
synthesi
brief
five
long
oligo
averag
nucleotid
length
nucleotid
overlap
synthes
hplcpurifi
operon
biotechnolog
minigen
assembl
extend
five
overlap
oligo
confirm
nucleotid
sequenc
dna
sequenc
multiepitop
minigen
clone
noti
ecori
site
express
vector
sigmaaldrich
vector
encod
three
adjac
flagtag
epitop
amino
acid
sequenc
dykdhdgdykdhdidykddddk
upstream
multipl
clone
region
henc
express
ntermin
fusion
protein
control
cmv
promot
mammalian
cell
recombin
adenoviru
express
eight
predict
epitop
gener
use
adenoviru
express
vector
kit
takara
bio
inc
shiga
japan
briefli
minigen
link
sequenc
isol
pcr
amplif
insert
clone
site
cosmid
vector
paxcawtit
contain
entir
adenoviru
genom
except
gene
recombin
cosmid
cotransfect
dnatpc
contain
adenoviru
termin
protein
cell
lipofectamin
invitrogen
carlsbad
ca
sinc
cell
express
replicationdefect
adenoviru
produc
clone
viru
amplifi
cell
titer
standard
plaqu
assay
cell
wildtyp
adenoviru
adwt
use
neg
control
recombin
vaccinia
viru
wr
strain
express
eight
predict
epitop
gener
describ
brief
minigen
sequenc
insert
transfer
vector
gener
homolog
recombin
wildtyp
vaccinia
viru
vvwt
transfer
vector
purifi
three
cycl
plaqu
clone
cell
presenc
bromodeoxyuridin
propag
cell
viral
titer
measur
standard
plaqu
assay
cell
detect
express
fusion
protein
western
blot
perform
describ
previous
brief
cell
infect
multipl
infect
moi
moi
h
day
incub
cell
lyse
solubil
protein
separ
electrophoresi
sdspage
reduc
condit
blot
onto
nitrocellulos
membran
blot
stain
gml
antiflag
mab
sigmaaldrich
follow
secondari
stain
peroxidas
conjug
antimous
igg
ab
protein
band
develop
bcipnbt
phosphatas
substrat
system
kpl
inc
gaithersburg
md
oleoyl
liposom
compos
dioleoyl
phosphatidyl
cholin
dioleoyl
phosphatidyl
ethanolamin
dioleoyl
phosphatidyl
glycerol
acid
cholesterol
molar
ratio
ctl
peptid
helper
peptid
coupl
surfac
liposom
molar
concentr
via
disuccinimidyl
suber
dss
describ
previous
empti
liposom
use
neg
control
identif
ctl
epitop
mice
immun
intraperiton
ip
plaqueform
unit
pfu
either
adwt
immun
liposom
peptid
mice
subcutan
sc
immun
surfacelink
liposom
ctl
peptid
gmous
mix
liposom
helper
peptid
gmous
cpgodn
hokkaido
system
scienc
sapporo
japan
gmous
l
pb
footpad
intracellular
cytokin
stain
ic
perform
describ
previous
briefli
week
follow
immun
spleen
cell
immun
mice
incub
brefeldin
golgiplug
bd
bioscienc
h
c
presenc
absenc
relev
peptid
final
concentr
incub
rat
antimous
mab
fc
block
bd
bioscienc
cell
stain
fitcconjug
rat
antimous
mab
bd
bioscienc
min
c
cell
fix
permeabil
stain
phycoerythrin
pe
conjug
rat
antimous
mab
bd
bioscienc
wash
cell
flow
cytometr
analys
perform
crreleas
assay
carri
describ
brief
week
follow
immun
spleen
cell
immun
mice
cultur
week
irradi
gy
syngen
naiv
spleen
cell
prepuls
relev
peptid
employ
effector
cell
standard
crreleas
assay
rmahhd
cell
puls
without
peptid
h
label
ci
na
cro
use
target
cell
incub
supernat
well
harvest
radioact
count
result
calcul
mean
triplic
assay
percent
specif
lysi
calcul
accord
formula
specif
lysi
cpm
sampl
cpm
spontan
cpm
maximum
cpm
spontan
spontan
releas
repres
radioact
releas
target
cell
absenc
effector
maximum
releas
repres
radioact
releas
target
cell
lyse
triton
vivo
ctl
assay
carri
report
briefli
spleen
cell
naiv
hhd
mice
equal
split
two
popul
one
popul
puls
peptid
final
concentr
h
c
label
high
concentr
viral
challeng
experi
perform
describ
two
week
immun
mice
challeng
ip
pfu
either
vvwt
five
day
later
mice
sacrif
two
ovari
mous
homogen
resuspend
ml
pb
contain
fc
mm
mgcl
viru
releas
cell
three
freezethaw
cycl
follow
sonic
viral
titer
measur
plate
serial
dilut
indic
cell
plate
titrat
perform
duplic
averag
pfu
per
mous
calcul
statist
analys
perform
student
ttest
valu
p
consid
statist
signific
amino
acid
sequenc
sarscovn
search
potenti
hlaa
ctl
epitop
two
computerbas
program
syfpeithi
bima
accord
score
calcul
eight
nonamer
decamer
peptid
select
synthes
tabl
evalu
bind
affin
peptid
hlaa
molecul
peptid
bind
assay
perform
tabl
five
eight
peptid
high
binder
display
bl
valu
less
two
medium
binder
display
bl
valu
rang
data
suggest
predict
ctl
epitop
mostli
success
contrast
one
peptid
show
low
affin
bind
investig
whether
ctl
specif
predict
peptid
elicit
hhd
mice
immun
ip
either
adwt
one
week
immun
spleen
cell
prepar
stimul
eight
predict
peptid
deriv
sarscovn
h
cell
stain
surfac
express
antigeninduc
intracellular
express
shown
fig
consider
number
cell
induc
stimul
peptid
includ
mice
adwtinject
mice
indic
ctl
specif
four
peptid
induc
mice
immun
contrast
none
remain
peptid
significantli
elicit
cell
fig
next
examin
peptidespecif
kill
activ
spleen
cell
mice
immun
two
week
immun
spleen
cell
mice
harvest
stimul
vitro
peptid
one
week
later
crreleas
assay
perform
variou
effector
target
e
ratio
agreement
data
ic
fig
four
peptid
fig
fig
fig
fig
elicit
strong
peptidespecif
ctl
respons
mice
adwtinfect
mice
hand
remain
peptid
fig
fig
fig
fig
fail
induc
ctl
activ
either
mice
adwtinject
mice
address
peptidespecif
kill
activ
mice
vivo
ctl
assay
carri
fig
immun
either
adwt
hhd
mice
receiv
iv
inject
peptidepuls
cfse
high
target
unpuls
cfse
low
target
twelv
hour
later
spleen
cell
prepar
peptidespecif
lysi
assess
flow
cytometri
expect
ctl
kill
activ
significantli
detect
mice
immun
adwtinject
mice
fig
especi
activ
kill
greatest
fig
suggest
might
immunodomin
epitop
remain
peptid
could
induc
peptidespecif
kill
activ
vivo
ctl
assay
data
shown
next
investig
whether
surfacelink
liposom
peptid
could
induc
peptidespecif
ctl
mice
sinc
four
peptid
includ
expect
hlaa
ctl
epitop
fig
peptid
chemic
conjug
surfac
liposom
surfacelink
liposom
peptid
evalu
capabl
ctl
induct
hhd
mice
one
week
immun
liposom
peptid
spleen
cell
prepar
stimul
relev
peptid
stain
express
surfac
intracellular
shown
fig
signific
number
cell
elicit
mice
immun
either
footpad
case
howev
one
inject
result
induct
cell
fig
three
inject
signific
expans
cell
respons
final
observ
fig
indic
might
less
immunogen
hand
fail
elicit
cell
mice
fig
even
multipl
inject
sinc
peptid
compos
peptid
one
addit
leucin
nterminu
tabl
possibl
cross
reaction
shown
fig
peptid
obvious
stimul
cell
mice
immun
demonstr
ctl
prime
activ
stimul
well
contrast
either
could
induc
cell
mice
prime
effect
prime
cell
mice
fig
next
evalu
whether
immun
either
would
induc
ctl
kill
peptidepuls
target
cell
vivo
one
week
immun
mice
peptidepuls
cfse
high
target
cell
unpuls
cfse
low
target
cell
deliv
mice
via
iv
inject
shown
fig
peptidespecif
kill
activ
mice
greater
mice
indic
immunogen
therefor
next
test
whether
mice
immun
abl
clear
viru
challeng
hhd
mice
immun
twice
interv
two
week
last
immun
mice
challeng
pfu
vvwt
day
follow
challeng
viral
titer
measur
two
ovari
mous
shown
fig
titer
vaccinia
viru
mice
challeng
log
lower
mice
challeng
vvwt
mice
immun
empti
liposom
retain
high
viral
titer
challeng
either
fig
vvwt
data
shown
thu
data
indic
immun
effect
protect
viru
fig
ctl
activ
specif
eight
predict
epitop
deriv
sarscovn
mice
immun
hhd
mice
immun
ip
either
revers
triangl
adwt
circl
two
week
immun
spleen
cell
prepar
stimul
vitro
eight
predict
epitop
deriv
sarscov
n
protein
week
crreleas
assay
perform
variou
e
ratio
rmahhd
cell
puls
open
symbol
without
solid
symbol
relev
peptid
target
data
shown
mean
sd
triplic
well
experi
repeat
twice
similar
result
least
three
mice
per
group
use
experi
sinc
protein
respons
bind
specif
cellular
receptor
major
target
neutral
antibodi
moreov
vigor
sspecif
ctl
respons
gener
sarscovinfect
patient
indic
protein
antigen
ctl
well
fact
four
ctl
epitop
deriv
protein
identifi
howev
sinc
n
protein
conserv
synthes
earlier
protein
n
protein
seem
prefer
protein
antigen
target
tcell
immun
therefor
focus
sarscov
n
protein
develop
ctlbase
vaccin
current
studi
highperform
comput
algorithm
extens
use
identif
ctl
epitop
chentoufi
et
al
support
predict
comput
algorithm
multipl
immunolog
screen
thu
import
use
multipl
screen
success
identif
function
ctl
epitop
also
perform
multipl
immunolog
screen
includ
cell
surfac
stabil
hlaa
molecul
cell
detect
antigendriven
cell
function
vivo
vitro
ctl
assay
strategi
identif
ctl
epitop
sever
advantag
first
use
recombin
adenoviru
vaccinia
viru
allow
us
circumv
necess
handl
live
sarscov
recombin
virus
carri
multiepitop
minigen
encod
eight
predict
epitop
sever
natur
flank
amino
acid
residu
end
therebi
offer
natur
antigen
process
infect
cell
basic
idea
come
observ
flank
sequenc
proxim
ctl
epitop
modul
proteasom
process
epitop
furthermor
carri
vitro
vivo
experi
use
virus
facil
replicationdefect
recombin
adenoviru
effect
induc
ctl
specif
protein
encod
gene
insert
viral
genom
recombin
vaccinia
viru
employ
viru
challeng
protect
experi
second
use
highli
reactiv
hlaa
transgen
mice
term
hhd
mice
innat
b
mous
gene
disrupt
homolog
recombin
hhd
mice
mhc
class
molecul
cell
surfac
hlaa
effici
util
hlaa
ctl
use
lymphocyt
hhd
mice
infect
replac
pbl
sar
patient
consequ
identifi
three
hla
ctl
epitop
deriv
sarscovn
ident
report
tsao
et
al
indic
approach
prove
practic
epitop
identif
virus
howev
taken
account
may
differ
immunogen
variat
observ
hla
class
transgen
mice
human
primarili
antigen
process
present
ultim
immunodomin
may
differ
necessari
use
sarscov
viral
challeng
experi
final
stage
peptid
unlik
epitop
ctl
could
induc
immun
fig
howev
ctl
prime
activ
stimul
well
fig
accordingli
interpret
data
concern
fig
could
propos
explan
immun
mice
induc
ctl
fig
resist
infect
vaccinia
viru
express
mice
immun
hhd
mice
immun
twice
either
empti
liposom
emptylip
along
liposom
helper
peptid
cpg
interv
two
week
later
mice
challeng
ip
pfu
either
vvsar
vvwt
mice
sacrif
day
challeng
viral
titer
ovari
measur
titrat
perform
duplic
averag
pfu
per
mous
shown
figur
three
mice
use
group
data
shown
mean
sd
three
mice
p
ctl
recogn
well
fig
current
studi
shown
surfacelink
liposom
peptid
effect
induct
peptidespecif
ctl
mice
well
recombin
adenoviru
fig
note
immunogen
liposom
peptid
effici
induc
protect
viral
challeng
vaccinia
viru
express
fig
data
strongli
suggest
surfacelink
liposom
peptid
may
offer
effect
safe
ctlbase
vaccin
sar
howev
vivo
ctl
activ
induc
immun
half
induc
fig
although
level
cell
similar
immun
fig
data
might
suggest
liposom
disturb
ctl
kill
activ
degre
furthermor
number
cell
specif
elicit
mice
receiv
one
inject
fig
contrast
three
inject
requir
signific
induct
ctl
mice
fig
data
might
suggest
exogen
peptid
conjug
surfac
liposom
may
process
present
peptidespecif
ctl
differ
way
natur
process
endogen
peptid
deriv
adenoviru
surfacelink
liposom
peptid
might
similar
lipopeptid
form
palmitoyllipid
peptid
current
intens
investig
human
vaccin
mani
infecti
pathogen
cancer
although
effect
induc
peptidespecif
ctl
sever
differ
fist
selfadjuv
lipopeptid
stimul
peptidespecif
ctl
via
tolllik
receptor
tlr
without
particular
adjuv
contrast
induct
ctl
surfacelink
liposom
peptid
requir
extern
tlr
ligand
cpg
howev
well
known
cpg
caus
toxic
human
henc
essenti
find
safe
adjuv
clinic
use
liposom
peptid
second
lipopeptid
administ
intranas
sublingu
intravagin
abl
induc
mucos
system
immun
respons
applic
offer
advantag
needlefre
deliveri
howev
still
investig
whether
surfacelink
liposom
peptid
intranas
stimul
peptidespecif
ctl
summari
first
tri
identifi
hlaa
ctl
epitop
deriv
n
protein
sarscov
use
comput
algorithm
recombin
adenoviru
hlaa
transgen
mice
four
peptid
expect
epitop
chemic
conjug
surfac
liposom
shown
two
liposom
peptid
effect
peptidespecif
ctl
induct
immunogen
liposom
peptid
effici
induc
protect
viral
challeng
vaccinia
viru
express
peptid
data
suggest
surfacelink
liposom
peptid
may
use
ctlbase
immunotherapi
sar
